Response to Tanezumab, as assessed by outcome measures in rheumatology-osteoarthritis research society international criteria, in patients with osteoarthritis of the knee or hip. (April 2018) - Schnitzer, T.J.; Bello, A.E.; West, C.R.; Pixton, G.C.; Tive, L.